The observation by Hunter 6 that an articular cartilage (AC) lesion is a problem that will not heal is just as relevant today as it was 250 years ago. Despite recent advancements, the challenge of treating AC lesions may be even greater now due to the current emphasis on physical fitness and the expectation that advances in technology will solve even the most difficult medical conditions. Progress in the effort to restore the complex and highly specialized composition of normal AC, and in the restoration of it, satisfy patientÕs expectations, requires transcendent basic science and clinical research.
Basic science research has demonstrated that one of the intrinsic challenges of artificial replacement of AC is replicating the special nature of this tissue. Articular cartilage is uniquely resilient and non-uniform. The structure is zonal, rising from fibrous integration with the calcified cartilage layer at the bone interface to the smooth and frictionless surface adjacent to the synovial cavity. Its individually protected cells, the chondrocytes, are surrounded by a casing (chondron) of specialized collagen fibers protecting them from compressive forces, while still allowing signaling, both biomechanical and molecular, to penetrate to the cell. At the molecular level, AC consists of a unique pattern of interwoven collagen fibers surrounding huge aggregates of negatively charged proteoglycan molecules imbibed with water. To date, there is no artificial or derived matrix that replicates this complex structure, and hence the functionality of normal human AC, in its entirety.
The laboratory challenges in elucidating the procedures for successful AC repair are numerous. If autologous AC is used, what location is best for harvest and will this violated site then become a potential joint integrity complication in the future? Is it necessary to preserve the cellular content of the donor AC or can the matrix be repopulated with either new, younger, and/or stimulated chondrocytes or stem cells? How do we ensure that the cells retain their normal chondrocyte properties in the replacement constructs? 13 Allograft tissue, although providing a greater supply of a more matched tissue, introduces a new set of problems, the first of which are obtaining a convenient source of available tissue and the possible risk of disease transmission from donors. How long can allograft tissue be stored 10 and how can the special structure of the AC be maintained during storage and transfer? How should the replacement AC be inserted, fitted, attached, and leveled?
1 Can the ''fit'' be helped by using reshaping or artificial matrices? 4 Should the environment into which the new AC is being fitted be modified in any way to accept the new tissue? Do we enhance the replacement by adding proteinase inhibitors or growth factors? 9 How do we know whether the replaced tissue is working or not? Diagnostic procedures to measure the quantity, let alone the quality, of AC are in their infancy and are not widely available.
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Clinical research has revealed that extrinsic challenges also create an impediment to progress in AC repair. Differences in patient-specific factors, the various surgical techniques, different rehabilitation protocols, and methods to evaluate results contribute to the controversy over which method of repair produces the highest quality and most durable repair tissue.
Degeneration of articular cartilage can be initiated by a number of precipitating conditions, whether it be traumatic cartilage injury, destabilization from other joint tissue failures, or the consequence of a disease process. A hostile local environment generated by comorbidities such as meniscectomy, malalignment, or obesity must be to be corrected or the articular cartilage repair will suffer the same degenerative fate as the original tissue.
The patient-specific factors, age of the patient, duration of symptoms, and defect size and location have an important influence on the results of treatment. The studies of de Windt et al, 3 and Saris et al 12 on autologous chondrocyte implantation (ACI) and microfracture found better outcomes for early compared with late treatment of defects and for younger compared with older patients. A systematic review of return to sports by Mithoefer et al 8 also found that the rate of return increased 5-fold for microfracture and up to 3-fold for ACI if surgery was performed within 1 year of the cartilage injury. These results suggest that untreated cartilage defects may result in an unfavorable environment due to degeneration in the surrounding cartilage. They also found that the age of the patient significantly affected return to sports after all AC repair techniques. One explanation for the increased rate of return was the increase in metabolic activity and matrix synthesis in the repair cartilage in young patients.
Location of the lesion is another factor that may influence results. Saris et al 12 and de Windt et al 3 found that defects on the medial femoral condyle treated with ACI or microfracture had better results than defects on the lateral femoral condyle. Although no comparative studies were performed, the results of ACI for treatment of patellofemoral and talar chondral defects appeared to be comparable with the results of ACI in the knee.
Contrary to clinical intuition, various studies have not shown a consistent relationship between defect size and the clinical outcome after ACI. In contrast, some studies have found that the results of microfracture were worse 
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Editorial for lesions larger than 2 cm 2 . However, the results of microfracture were independent of defect size in the study of de Windt et al. 3 Thus, defect size may be a predictor of outcome for some treatments, but not others.
The current lack of an evidenced-based consensus creates another challenge in determining which of the surgical techniques replicates the structure, function, and durability of AC with greatest fidelity. In level 1 studies, Knutsen et al 7 found no difference between ACI and microfracture at 5 years, whereas Saris et al 12 demonstrated that the results of ACI with characterized chondrocytes selected to preserve chondrogenecity and phenotypic characteristics were better than microfracture. They also found that patients implanted with cells having higher gene profile scores had better results. Consequently, the AC phenotype appears to enhance the potential for hyaline-like cartilage regeneration.
Classic ACI has been associated with several limitations including the morbidity of the procedure and a high reoperation rate due to periosteal flap hypertrophy. Gomoll et al 5 found that the use of a type I/III bilayer collagen membrane decreased the morbidity and the reoperation rate from 25.7% to 5%. Matrix-assisted or second-generation ACI was developed to address all of the limitations of classic ACI. The concept was based on the use of biodegradable polymers as temporary 3-dimensional scaffolds for in vitro growth and transplantation. This technique favors maintenance of the differentiated chondrocyte phenotype. Morbidity of matrix-assisted ACI is minimized because the technique may be performed arthroscopically or through a small arthrotomy. Although this is a promising technique, insufficient data are available on clinical applications of all the different matrix products.
Another factor contributing to controversy is the lack of research on the optimal rehabilitation protocol for different methods of AC repair. Rehabilitation programs have typically delayed weight bearing due to uncertainty about the biomechanical properties and load bearing capability of the graft. Nevertheless, weight bearing and joint movement are necessary to maintain joint homeostasis and mechanical forces modulate chondrocyte differentiation and articular matrix synthesis in the graft. The studies of Della Villa et al 2 and Wondrasch et al 14 demonstrated that accelerated weight bearing and intensive rehabilitation after second-generation ACI leads to good clinical outcomes without jeopardizing the graft.
The patient-reported and objective methods used to evaluate outcomes are critical to interpretation of results. The patient-reported outcome measures with the best psychometric properties for interpretation of results of cartilage repair in the knee are the International Knee Documentation Committee (IKDC) Subjective Knee Form and Knee Injury and Osteoarthritis Outcome Score (KOOS). Objective assessment of repair tissue quality is the best prognostic factor for durability of good clinical outcomes. Arthroscopy with mechanical probing and biopsy for microscopic and histological analysis is currently the gold standard for assessment of the repair tissue. Even so, limitations preclude the routine use of this method of assessment. Clinical studies in this supplement evaluated patients with MRI and dGEMRIC, MRI graded with the Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) scoring system and T2 mapping, and SPECT-CT analysis, which provide valuable information regarding the quantity and quality of the repair tissue, elevation of the subchondral bone, subchondral bone cysts, and edema.
Although many questions remain unanswered, the rapid progress that is being made today in basic science and clinical research provides assurance that eventually a cure will be found for the insuperable condition described by Hunter so long ago.
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